Absinthiin
CAS No. 1362-42-1
Absinthiin( Absinthin | NSC 407315 | NSC-407315 )
Catalog No. M17973 CAS No. 1362-42-1
Absinthiin is a weak HIV-1 protease inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAbsinthiin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbsinthiin is a weak HIV-1 protease inhibitor.
-
DescriptionAbsinthin is possible treatment candidate for Acute lung injury (ALI). ALI symptoms include severe lung inflammation. Absinthin causes an anti-inflammatory effect by enhancing activity of matrix metalloproteinase-8 (MMP-8), which inhibits grwoth of inflammatory cells.
-
In Vitro——
-
In VivoAnimal Model:LPS-induced acute lung injury in miceDosage:20, 40, 80mg/kg Administration:p.o.Result:Reduced inflammatory cell infiltration and improved lung architecture.Reduced MPO activity, infiltration of neutrophils, lung tissue wet-to-dry ratio.Reduced the secretion of proinflammatory cytokines and chemokines (TNF-α, IL-1β, IL-6, and MIP-1α).
-
SynonymsAbsinthin | NSC 407315 | NSC-407315
-
PathwayOthers
-
TargetOther Targets
-
RecptorHIV-1 protease
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number1362-42-1
-
Formula Weight496.64
-
Molecular FormulaC30H40O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1C2CCC(C3C4C5C=C(C6(C4C(=C3C2OC1=O)C)C5C(CCC7C6OC(=O)C7C)(C)O)C)(C)O
-
Chemical Name[no name]
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
7-Xylosyl-10-deacety...
7-Xylosyl-10-deacetyltaxol paclitaxel is a Paclitaxel derivative with improved pharmacological features and higher water solubilityused in Chinese clinics to treat cancer.
-
2'-Deoxyuridine 5'-m...
2'-Deoxyuridine 5'-monophosphate (dUMP) is used by the enzyme thymidylate synthetase (TS) for the de novo production of dTMP. dUMP is used as the reference substrate in studies of dUMP analogues in potential chemotherapy applications.
-
Irtemazole
Irtemazole (R 60844) is a novel uricosuric substance that is valuable in the treatment of hyperuricemia and gout.
Cart
sales@molnova.com